Latest News
Nektar closes sale of specific pulmonary delivery assets to Novartis for $115 mn
Pharmabiz.com (India) | 20 minutes ago
Nektar Therapeutics has successfully closed the divestiture of specific Nektar pulmonary delivery assets, technology, and intellectual property to Novartis for $115 million in cash. The transaction was completed on December 31, 2008.... (more)
Scientist at Work - Rob Holman - So Much to Learn About the Oceans From Sand - Biography - NYTimes.com
New York Times, The | 22 minutes ago
CORVALLIS, Ore. As a young geophysicist in the 1980s, Rob Holman attended a conference in San Francisco that included a field trip to a beach. Dr. Holman, who grew up inland, in Ottawa, stared at the ocean, assessing the strengths and vectors of the waves and currents. But when he looked around, everyone else was studying the sand. He realized, he recalled, that sand is not the same everywhere. So he started collecting it. I collected a few samples and put them in jars, he said. Then...... (more)
CRIME REPORT: Cars pounded by rocks hurled from bridge over Paul Barret Parkway : Local News : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 2 hours 22 minutes ago
Three vehicles, including a patrol car, have been pounded by rock or concrete chunks hurled from the Donnell Road bridge over Paul Barret Parkway in North Shelby County.... (more)
Cigna to cut about 1,100 jobs, 4 pct of work force
Boston Globe, The | 2 hours 26 minutes ago
INDIANAPOLIS—Managed care provider Cigna Corp. said Monday the slumping economy has forced it to cut roughly 1,100 jobs, as it deals with employer customers who also are making cuts and reducing the number of people covered by insurance.... (more)
Endo to buy Indevus for $370 million upfront
Boston Globe, The | 2 hours 26 minutes ago
NEW YORK—Endo Pharmaceutical Holdings Inc. said Monday it will buy Indevus Pharmaceuticals Inc. for $370 million upfront, or $4.50 per share, acquiring Invedus' urology and hormone drug candidates in the process.... (more)
Investor's Business Daily: Biotech Firm Sticks To Its Work While Drug Giant Roche Circles
Investor's Business Daily | 3 hours 14 minutes ago
Posted 1/5/2009 Last summer, Genentech (DNA) rejected Swiss drug maker Roche Holding's $43.7 billion offer to buy the company. The $89-a-share bid was too low, the biotech giant's board said, but it kept the door open for a higher bid.... (more)
Biogen shares fall on JP Morgan downgrade - Forbes.com
Forbes | 5 hours 1 minute ago
Shares of Biogen Idec Inc. fell Monday after JP Morgan cut its rating on the stock, saying the multiple sclerosis drug Tysabri could continue facing challenges in 2009 while the company lacks any catalysts to drive new revenue.... (more)
Takeover of Alpharma Will Give Actavis Rights to Kadian
FDAnews | 5 hours 2 minutes ago
King Pharmaceuticals’ acquisition of Alpharma, completed last week, will give the merged company an expanded pain drug portfolio that will include the muscle relaxant Skelaxin, the Flector patch and Embeda.... (more)
Insurer Cigna to cut about 1,100 jobs, or 4 percent of its work force, in response to economy
Hartford Courant (Conn.), The | 5 hours 7 minutes ago
INDIANAPOLIS (AP) — Managed care provider Cigna Corp. said Monday the slumping economy has forced it to cut roughly 1,100 jobs, as it deals with employer customers who also are making cuts and reducing the number of people covered by insurance.... (more)
Endo To Buy Indevus - Forbes.com
CNS Magazine | 5 hours 8 minutes ago
Endo Pharmaceuticals, best known for the pain drugs Percocet and Lidoderm, plans to purchase Indevus Pharmaceuticals, a maker of treatments for urinary incontinence for $370 million in cash now and, in a twist, $267 million more if it hits certain regulatory and sales milestones, the companies said.... (more)
105 Stories |
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
Cigarette taxes are bad for your health?
Healthcare Economist
Healthcare Economist tops the charts
Healthcare Economist
The big Twitter Health care list
Health Care Blog, The
Health IT On Obama Agenda
Health Affairs blog
Companies in the news
- Amgen Inc.
- Biovail Corp
- Caraco Pharmaceutical
- CareFirst
- Fresenius Medical Care
- Genentech Inc
- Health Care
- Labopharm Inc
- Logistics
- Mosaic
- Patterson
- Ranbaxy Laboratories Ltd.
- Sankyo Co LTD
- Shelby County
- St. Jude Children Research Hospital
